43 Kazia Theraputics Limited Annual Report 2023 Chairman and CEO’s Letter Key Milestones Introduction to Kazia’s CEO Pipeline Review Environment, Society and Governance Financial Reports STATEMENT OF FINANCIAL POSITION As at 30 June 2023 Consolidated Note 2023 2022 restated 1 July 2021 restated $ $ $ Assets Current assets Cash and cash equivalents 10 5,241,197 7,361,112 27,586,760 Trade and other receivables 11 3,899,154 90,975 84,362 Other assets 13 1,632,472 1,997,205 1,719,696 Total current assets 10,772,823 9,449,292 29,390,818 Non-current assets Intangibles 14 17,269,432 19,138,892 21,008,312 Trade & other receivables - non-current 12 42,922 7,300,870 6,693,628 Total non-current assets 17,312,354 26,439,762 27,701,940 Total assets 28,085,177 35,889,053 57,092,758 Liabilities Current liabilities Trade and other payables 15 4,328,949 3,760,120 4,932,660 Borrowings 16 1,796,500 1,841,052 – Employee benefits 17 689,802 368,616 229,337 Contingent consideration 18 750,000 758,840 791,139 Total current liabilities 7,565,251 6,728,628 5,953,136 Non-current liabilities Deferred tax 19 2,289,269 2,560,361 2,928,441 Employee benefits 17 59,323 116,596 54,684 Contingent consideration 18 6,120,783 8,208,945 10,303,302 Total non-current liabilities 8,469,375 10,885,902 13,286,427 Total liabilities 16,034,626 17,614,530 19,239,563 Net assets 12,050,551 18,274,523 37,853,195 Equity Contributed equity 20 97,452,246 84,480,249 80,290,062 Other contributed equity – – 464,000 Reserves 21 3,680,876 2,411,665 1,300,566 Accumulated losses (89,082,571) (68,617,391) (44,201,433) Total equity 12,050,551 18,274,523 37,853,195 Refer to note 4 for detailed information on restatement of comparatives. Refer to note 5 for detailed information on reclassification of comparatives. The above statement of financial position should be read in conjunction with the accompanying notes
RkJQdWJsaXNoZXIy MjE2NDg3